Therapy News and Research

RSS

Researchers receive €10.6 million to develop new therapeutic approaches to target glioblastoma

Researchers at the Universities of Amsterdam and Leiden together with the Netherlands Cancer Institute (Amsterdam) and Oncode Institute (Utrecht) have received a €10.6 million ERC Synergy Grant to develop innovative therapeutic approaches to target glioblastoma, a deadly primary brain tumor for which no curing therapy is yet available.

26 Oct 2023

Doubts abound about a new Alzheimer’s blood test

For the first time, people worried about their risk of Alzheimer's disease can go online, order a blood test, and receive results in the privacy of their homes.

26 Oct 2023

New Sartorius Digital Handbook brings the power of High-Throughput Screening (HTS) by cytometry to every scientist

Sartorius, an industry-leading innovator of advanced instruments for cell analysis has released its first Advanced Flow Cytometry Handbook as a comprehensive digital guide to assays and workflows on the iQue® Advanced High Throughput Flow Cytometry Platform.

From Sartorius 26 Oct 2023

Stanford chemists uncover new pathway for protein degradation, opening door to new therapeutics

When targeting problem proteins involved in causing or spreading disease, a drug will often clog up a protein's active site so it can't function and wreak havoc.

25 Oct 2023

Boosting brain health with iron and manganese: A dietary defense against cognitive decline

The recent study published in Nutrients explores the link between dietary mineral intake and cognitive impairment in elderly Spanish individuals, finding that increased consumption of iron and manganese significantly reduced cognitive impairment risk in women but showed no effect in men.

25 Oct 2023

Newly identified small molecule can suppress growth of breast and ovarian cancers in animal models

Researchers at Baylor College of Medicine have identified a small molecule named 5D4 that can suppress the growth of breast and ovarian cancers in animal models.

25 Oct 2023

New study aims to discover whether insomnia treatment can reduce cardiovascular disease risks

It's no secret that a good night's rest can do wonders for one's health, but those who struggle with insomnia have a nearly 50% increased risk of cardiovascular disease.

25 Oct 2023

How strep bacteria outsmart your immune system and why it matters for treatment

Researchers discover that Group A streptococcal infections alter immunoglobulin G (IgG) homeostasis to evade the immune system, affecting the transition from local to systemic infections. The study also raises concerns about the effectiveness of antibody-based therapies, as the bacteria's virulence factors can degrade therapeutic antibodies.

25 Oct 2023

Anti-anxiety drug can improve the effectiveness of chemo-radiotherapy towards glioblastoma

A new research study shows that cerebrospinal fluid reduces current treatment efficacy in brain cancer and identifies new therapeutic opportunities.

25 Oct 2023

Study shows high prevalence of thyroid cancer among transgender female veterans

A new study by UC Davis Health endocrinology researchers has shown a high prevalence of thyroid cancer among transgender female veterans.

25 Oct 2023

Global clinical trial provides new evidence on simvastatin and vitamin C for COVID-19

The Global Coalition for Adaptive Research (GCAR) in collaboration with the University of Pittsburgh and UPMC, on behalf of the REMAP-CAP Investigator Network, announce clinical trial results examining the use of vitamin C and simvastatin to treat severely ill patients with COVID-19.

25 Oct 2023

New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.

25 Oct 2023

Lack of direct comparisons prevents assessment of upadacitinib's benefit in Crohn's disease

Like several immunosuppressive biologics, the JAK inhibitor upadacitinib is also approved for the treatment of Crohn's disease. Commissioned by the Federal Joint Committee (G-BA), the Institute for Quality and Efficiency in Health Care (IQWiG) has now investigated in an early benefit assessment whether the drug offers an added benefit versus the appropriate comparator therapy to patients with moderate to severe active Crohn's disease who have had an inadequate response, lost response or are intolerant to conventional therapy or a biologic agent.

25 Oct 2023

New study provides insights into the safety of novel therapies for pulmonary embolism

A large, modern real-world analysis published today in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI), provides vital insights into the safety of novel therapies including ultrasound-assisted catheter-directed thrombolysis (USCDT) and mechanical thrombectomy (MT) that have been developed to address the increased morbidity and mortality of elevated risk pulmonary embolism (PE). Findings were presented today at TCT 2023.

25 Oct 2023

Millions of Americans with mild cognitive impairment are undiagnosed, studies find

For many people, forgetting your keys or struggling to plan tasks can seem like a normal part of the aging process. But those lapses can actually be symptoms of something more serious: mild cognitive impairment, or MCI, which could be an early sign of Alzheimer's disease.

25 Oct 2023

Sphere Bio's Expansion and Vision

In this interview, Rob Trainor, the Vice President of Operations at Sphere Fluidics, sits down for an insightful conversation detailing the completion of Sphere Fluidics' new state-of-the-art facilities and the strategic decisions behind their office move and rebranding.

From Fluidic Sciences and Sphere Bio 25 Oct 2023

Dementia and cholesterol: investigating links and impacts of hormone replacement therapy

The relationships between hormone replacement therapy (HRT), serum cholesterol levels, and dementia incidence.

25 Oct 2023

Red grape polyphenol, resveratrol: a multifaceted therapeutic powerhouse under review

The therapeutic potential of resveratrol, a red grape polyphenol.

25 Oct 2023

Could the microbiome hold the key to diagnosing and treating biliary tract cancer?

A recent study in "Microorganisms" delves into the relationship between the microbiome and biliary tract cancer, revealing distinct microbial compositions in patients compared to healthy individuals. This research highlights potential diagnostic biomarkers and suggests that altering gut microbial composition might enhance responses to cancer immunotherapy.

24 Oct 2023

Ketogenic diet boosts IVF success for women with PCOS, study reveals

A recent study in the journal "Nutrients" investigated the effects of dietary interventions, including the Mediterranean diet (MD) and a very low-calorie ketogenic diet (VLCKD), on overweight or obese women with polycystic ovarian syndrome (PCOS) undergoing in vitro fertilization (IVF).

24 Oct 2023

Therapy News and Research

Researchers receive €10.6 million to develop new therapeutic approaches to target glioblastoma

Doubts abound about a new Alzheimer’s blood test

New Sartorius Digital Handbook brings the power of High-Throughput Screening (HTS) by cytometry to every scientist

Stanford chemists uncover new pathway for protein degradation, opening door to new therapeutics

Boosting brain health with iron and manganese: A dietary defense against cognitive decline

Newly identified small molecule can suppress growth of breast and ovarian cancers in animal models

New study aims to discover whether insomnia treatment can reduce cardiovascular disease risks

How strep bacteria outsmart your immune system and why it matters for treatment

Anti-anxiety drug can improve the effectiveness of chemo-radiotherapy towards glioblastoma

Study shows high prevalence of thyroid cancer among transgender female veterans

Global clinical trial provides new evidence on simvastatin and vitamin C for COVID-19

New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

Lack of direct comparisons prevents assessment of upadacitinib's benefit in Crohn's disease

New study provides insights into the safety of novel therapies for pulmonary embolism

Millions of Americans with mild cognitive impairment are undiagnosed, studies find

Sphere Bio's Expansion and Vision

Dementia and cholesterol: investigating links and impacts of hormone replacement therapy

Red grape polyphenol, resveratrol: a multifaceted therapeutic powerhouse under review

Could the microbiome hold the key to diagnosing and treating biliary tract cancer?

Ketogenic diet boosts IVF success for women with PCOS, study reveals

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News